Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 2917 to 2928 of 2928 entries
Sorted by: Best Match Show Resources per page
Characterization of Varicella-Zoster (VZV) Specific T Cell Response in Healthy Subjects and Transplanted Patients by Using Enzyme Linked Immunospot (ELISpot) Assays.

Vaccines

Cassaniti I, Ferrari A, Comolli G, Sarasini A, Gregorini M, Rampino T, Lilleri D, Baldanti F.
PMID: 34451999
Vaccines (Basel). 2021 Aug 06;9(8). doi: 10.3390/vaccines9080875.

Solid organ transplant recipients, due to the administration of post-transplant immunosuppressive therapies, are at greater risk of viral reactivation episodes, mainly from herpes viruses, including varicella-zoster virus (VZV). The aim of this pilot study was to develop functional immunological...

Cite
Cassaniti I, Ferrari A, Comolli G, et al. Characterization of Varicella-Zoster (VZV) Specific T Cell Response in Healthy Subjects and Transplanted Patients by Using Enzyme Linked Immunospot (ELISpot) Assays. Vaccines (Basel). 2021;9(8)doi: 10.3390/vaccines9080875.
Cassaniti, I., Ferrari, A., Comolli, G., Sarasini, A., Gregorini, M., Rampino, T., Lilleri, D., & Baldanti, F. (2021). Characterization of Varicella-Zoster (VZV) Specific T Cell Response in Healthy Subjects and Transplanted Patients by Using Enzyme Linked Immunospot (ELISpot) Assays. Vaccines, 9(8), . https://doi.org/10.3390/vaccines9080875
Cassaniti, Irene, et al. "Characterization of Varicella-Zoster (VZV) Specific T Cell Response in Healthy Subjects and Transplanted Patients by Using Enzyme Linked Immunospot (ELISpot) Assays." Vaccines vol. 9,8 (2021). doi: https://doi.org/10.3390/vaccines9080875
Cassaniti I, Ferrari A, Comolli G, Sarasini A, Gregorini M, Rampino T, Lilleri D, Baldanti F. Characterization of Varicella-Zoster (VZV) Specific T Cell Response in Healthy Subjects and Transplanted Patients by Using Enzyme Linked Immunospot (ELISpot) Assays. Vaccines (Basel). 2021 Aug 06;9(8). doi: 10.3390/vaccines9080875. PMID: 34451999; PMCID: PMC8402512.
Copy Download .nbib Format: NLM
A multinational case-control study comparing forensic and non-forensic patients with schizophrenia spectrum disorders: the EU-VIORMED project.

Psychological medicine

de Girolamo G, Iozzino L, Ferrari C, Gosek P, Heitzman J, Salize HJ, Wancata J, Picchioni M, Macis A, Ahmed S.
PMID: 34511148
Psychol Med. 2021 Sep 13;1-11. doi: 10.1017/S0033291721003433. Epub 2021 Sep 13.

BACKGROUND: The relationship between schizophrenia and violence is complex. The aim of this multicentre case-control study was to examine and compare the characteristics of a group of forensic psychiatric patients with a schizophrenia spectrum disorders and a history of...

Cite
de Girolamo G, Iozzino L, Ferrari C, et al. A multinational case-control study comparing forensic and non-forensic patients with schizophrenia spectrum disorders: the EU-VIORMED project. Psychol Med. 2021;1-11doi: 10.1017/S0033291721003433.
de Girolamo, G., Iozzino, L., Ferrari, C., Gosek, P., Heitzman, J., Salize, H. J., Wancata, J., Picchioni, M., Macis, A., & Ahmed, S. (2021). A multinational case-control study comparing forensic and non-forensic patients with schizophrenia spectrum disorders: the EU-VIORMED project. Psychological medicine, 1-11. https://doi.org/10.1017/S0033291721003433
de Girolamo, Giovanni, et al. "A multinational case-control study comparing forensic and non-forensic patients with schizophrenia spectrum disorders: the EU-VIORMED project." Psychological medicine vol. (2021): 1-11. doi: https://doi.org/10.1017/S0033291721003433
de Girolamo G, Iozzino L, Ferrari C, Gosek P, Heitzman J, Salize HJ, Wancata J, Picchioni M, Macis A, Ahmed S. A multinational case-control study comparing forensic and non-forensic patients with schizophrenia spectrum disorders: the EU-VIORMED project. Psychol Med. 2021 Sep 13;1-11. doi: 10.1017/S0033291721003433. Epub 2021 Sep 13. PMID: 34511148.
Copy Download .nbib Format: NLM
Step-by-Step Cadaver Dissection and Surgical Technique for Compartmental Tongue and Floor of Mouth Resection.

Frontiers in oncology

Grammatica A, Piazza C, Ferrari M, Verzeletti V, Paderno A, Mattavelli D, Schreiber A, Lombardi D, Fazio E, Gazzini L, Giorgetti G, Buffoli B, Rodella LF, Nicolai P, Calabrese L.
PMID: 33968719
Front Oncol. 2021 Apr 23;11:613945. doi: 10.3389/fonc.2021.613945. eCollection 2021.

BACKGROUND: The aim of oral cancer surgery is tumor removal within clear margins of healthy tissue: the latter definition in the literature, however, may vary between 1 and 2 cm, and should be intended in the three dimensions, which...

Cite
Grammatica A, Piazza C, Ferrari M, et al. Step-by-Step Cadaver Dissection and Surgical Technique for Compartmental Tongue and Floor of Mouth Resection. Front Oncol. 2021;11:613945doi: 10.3389/fonc.2021.613945.
Grammatica, A., Piazza, C., Ferrari, M., Verzeletti, V., Paderno, A., Mattavelli, D., Schreiber, A., Lombardi, D., Fazio, E., Gazzini, L., Giorgetti, G., Buffoli, B., Rodella, L. F., Nicolai, P., & Calabrese, L. (2021). Step-by-Step Cadaver Dissection and Surgical Technique for Compartmental Tongue and Floor of Mouth Resection. Frontiers in oncology, 11613945. https://doi.org/10.3389/fonc.2021.613945
Grammatica, Alberto, et al. "Step-by-Step Cadaver Dissection and Surgical Technique for Compartmental Tongue and Floor of Mouth Resection." Frontiers in oncology vol. 11 (2021): 613945. doi: https://doi.org/10.3389/fonc.2021.613945
Grammatica A, Piazza C, Ferrari M, Verzeletti V, Paderno A, Mattavelli D, Schreiber A, Lombardi D, Fazio E, Gazzini L, Giorgetti G, Buffoli B, Rodella LF, Nicolai P, Calabrese L. Step-by-Step Cadaver Dissection and Surgical Technique for Compartmental Tongue and Floor of Mouth Resection. Front Oncol. 2021 Apr 23;11:613945. doi: 10.3389/fonc.2021.613945. eCollection 2021. PMID: 33968719; PMCID: PMC8104033.
Copy Download .nbib Format: NLM
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes.

Brain pathology (Zurich, Switzerland)

Magrinelli F, Mariotto S, Nadali G, Todeschini G, Lanzafame M, Cavallaro T, Monaco S, Ferrari S.
PMID: 34327765
Brain Pathol. 2021 Nov;31(6):e13004. doi: 10.1111/bpa.13004. Epub 2021 Jul 30.

A 58-year-old male with B-cell chronic lymphocytic leukemia presented with fever, chest pain, and acute-onset neurological deficits suggestive of multiple strokes (A). Brain autopsy revealed softening areas in the brain parenchyma (B, C) corresponding to extensive necrosis (D) caused...

Cite
Magrinelli F, Mariotto S, Nadali G, et al. A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes. Brain Pathol. 2021;31(6):e13004doi: 10.1111/bpa.13004.
Magrinelli, F., Mariotto, S., Nadali, G., Todeschini, G., Lanzafame, M., Cavallaro, T., Monaco, S., & Ferrari, S. (2021). A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes. Brain pathology (Zurich, Switzerland), 31(6), e13004. https://doi.org/10.1111/bpa.13004
Magrinelli, Francesca, et al. "A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes." Brain pathology (Zurich, Switzerland) vol. 31,6 (2021): e13004. doi: https://doi.org/10.1111/bpa.13004
Magrinelli F, Mariotto S, Nadali G, Todeschini G, Lanzafame M, Cavallaro T, Monaco S, Ferrari S. A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes. Brain Pathol. 2021 Nov;31(6):e13004. doi: 10.1111/bpa.13004. Epub 2021 Jul 30. PMID: 34327765; PMCID: PMC8549026.
Copy Download .nbib Format: NLM
Heteronormativity and the Justification of Gender Hierarchy: Investigating the Archival Data From 16 European Countries.

Frontiers in psychology

Ferrari F, Imperato C, Mancini T.
PMID: 34393913
Front Psychol. 2021 Jul 29;12:686974. doi: 10.3389/fpsyg.2021.686974. eCollection 2021.

Within the framework of the System Justification Theory, this study tested on the archival data from 16 European countries the general hypothesis that homonegativity (HN), as an expression of gender binarism and heteronormativity, works as a legitimizing myth of...

Cite
Ferrari F, Imperato C, Mancini T. Heteronormativity and the Justification of Gender Hierarchy: Investigating the Archival Data From 16 European Countries. Front Psychol. 2021;12:686974doi: 10.3389/fpsyg.2021.686974.
Ferrari, F., Imperato, C., & Mancini, T. (2021). Heteronormativity and the Justification of Gender Hierarchy: Investigating the Archival Data From 16 European Countries. Frontiers in psychology, 12686974. https://doi.org/10.3389/fpsyg.2021.686974
Ferrari, Federico, et al. "Heteronormativity and the Justification of Gender Hierarchy: Investigating the Archival Data From 16 European Countries." Frontiers in psychology vol. 12 (2021): 686974. doi: https://doi.org/10.3389/fpsyg.2021.686974
Ferrari F, Imperato C, Mancini T. Heteronormativity and the Justification of Gender Hierarchy: Investigating the Archival Data From 16 European Countries. Front Psychol. 2021 Jul 29;12:686974. doi: 10.3389/fpsyg.2021.686974. eCollection 2021. PMID: 34393913; PMCID: PMC8359921.
Copy Download .nbib Format: NLM
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.

bioRxiv : the preprint server for biology

Cameroni E, Saliba C, Bowen JE, Rosen LE, Culap K, Pinto D, VanBlargan LA, De Marco A, Zepeda SK, Iulio JD, Zatta F, Kaiser H, Noack J, Farhat N, Czudnochowski N, Havenar-Daughton C, Sprouse KR, Dillen JR, Powell AE, Chen A, Maher C, Yin L, Sun D, Soriaga L, Bassi J, Silacci-Fregni C, Gustafsson C, Franko NM, Logue J, Iqbal NT, Mazzitelli I, Geffner J, Grifantini R, Chu H, Gori A, Riva A, Giannini O, Ceschi A, Ferrari P, Cippà P, Franzetti-Pellanda A, Garzoni C, Halfmann PJ, Kawaoka Y, Hebner C, Purcell LA, Piccoli L, Pizzuto MS, Walls AC, Diamond MS, Telenti A, Virgin HW, Lanzavecchia A, Veesler D, Snell G, Corti D.
PMID: 34931194
bioRxiv. 2021 Dec 20; doi: 10.1101/2021.12.12.472269.

The recently emerged SARS-CoV-2 Omicron variant harbors 37 amino acid substitutions in the spike (S) protein, 15 of which are in the receptor-binding domain (RBD), thereby raising concerns about the effectiveness of available vaccines and antibody therapeutics. Here, we...

Cite
Cameroni E, Saliba C, Bowen JE, et al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. bioRxiv. 2021;doi: 10.1101/2021.12.12.472269.
Cameroni, E., Saliba, C., Bowen, J. E., Rosen, L. E., Culap, K., Pinto, D., VanBlargan, L. A., De Marco, A., Zepeda, S. K., Iulio, J. D., Zatta, F., Kaiser, H., Noack, J., Farhat, N., Czudnochowski, N., Havenar-Daughton, C., Sprouse, K. R., Dillen, J. R., Powell, A. E., Chen, A., Maher, C., Yin, L., Sun, D., Soriaga, L., Bassi, J., Silacci-Fregni, C., Gustafsson, C., Franko, N. M., Logue, J., Iqbal, N. T., Mazzitelli, I., Geffner, J., Grifantini, R., Chu, H., Gori, A., Riva, A., Giannini, O., Ceschi, A., Ferrari, P., Cippà, P., Franzetti-Pellanda, A., Garzoni, C., Halfmann, P. J., Kawaoka, Y., Hebner, C., Purcell, L. A., Piccoli, L., Pizzuto, M. S., Walls, A. C., Diamond, M. S., Telenti, A., Virgin, H. W., Lanzavecchia, A., Veesler, D., Snell, G., & Corti, D. (2021). Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2021.12.12.472269
Cameroni, Elisabetta, et al. "Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift." bioRxiv : the preprint server for biology vol. (2021). doi: https://doi.org/10.1101/2021.12.12.472269
Cameroni E, Saliba C, Bowen JE, Rosen LE, Culap K, Pinto D, VanBlargan LA, De Marco A, Zepeda SK, Iulio JD, Zatta F, Kaiser H, Noack J, Farhat N, Czudnochowski N, Havenar-Daughton C, Sprouse KR, Dillen JR, Powell AE, Chen A, Maher C, Yin L, Sun D, Soriaga L, Bassi J, Silacci-Fregni C, Gustafsson C, Franko NM, Logue J, Iqbal NT, Mazzitelli I, Geffner J, Grifantini R, Chu H, Gori A, Riva A, Giannini O, Ceschi A, Ferrari P, Cippà P, Franzetti-Pellanda A, Garzoni C, Halfmann PJ, Kawaoka Y, Hebner C, Purcell LA, Piccoli L, Pizzuto MS, Walls AC, Diamond MS, Telenti A, Virgin HW, Lanzavecchia A, Veesler D, Snell G, Corti D. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. bioRxiv. 2021 Dec 20; doi: 10.1101/2021.12.12.472269. PMID: 34931194; PMCID: PMC8687478.
Copy Download .nbib Format: NLM
Chromoendoscopy Is Not Superior to White Light Endoscopy in Improving Adenoma Detection in Lynch Syndrome Cohort Undergoing Surveillance with High-Resolution Colonoscopy: A Real-World Evidence Study.

Digestive diseases (Basel, Switzerland)

Montale A, Buttitta F, Pierantoni C, Ferrari C, Cameletti M, Colussi D, Miccoli S, Bazzoli F, Turchetti D, Ricciardiello L.
PMID: 34515093
Dig Dis. 2021 Aug 24; doi: 10.1159/000518840. Epub 2021 Aug 24.

BACKGROUND: Endoscopic surveillance in patients with Lynch syndrome (LS) is crucial due to a genetically based high risk of colorectal cancer (CRC). We aimed to compare the adenoma detection rate (ADR) between high-resolution white light endoscopy (WLE) alone and...

Cite
Montale A, Buttitta F, Pierantoni C, et al. Chromoendoscopy Is Not Superior to White Light Endoscopy in Improving Adenoma Detection in Lynch Syndrome Cohort Undergoing Surveillance with High-Resolution Colonoscopy: A Real-World Evidence Study. Dig Dis. 2021;doi: 10.1159/000518840.
Montale, A., Buttitta, F., Pierantoni, C., Ferrari, C., Cameletti, M., Colussi, D., Miccoli, S., Bazzoli, F., Turchetti, D., & Ricciardiello, L. (2021). Chromoendoscopy Is Not Superior to White Light Endoscopy in Improving Adenoma Detection in Lynch Syndrome Cohort Undergoing Surveillance with High-Resolution Colonoscopy: A Real-World Evidence Study. Digestive diseases (Basel, Switzerland), . https://doi.org/10.1159/000518840
Montale, Amedeo, et al. "Chromoendoscopy Is Not Superior to White Light Endoscopy in Improving Adenoma Detection in Lynch Syndrome Cohort Undergoing Surveillance with High-Resolution Colonoscopy: A Real-World Evidence Study." Digestive diseases (Basel, Switzerland) vol. (2021). doi: https://doi.org/10.1159/000518840
Montale A, Buttitta F, Pierantoni C, Ferrari C, Cameletti M, Colussi D, Miccoli S, Bazzoli F, Turchetti D, Ricciardiello L. Chromoendoscopy Is Not Superior to White Light Endoscopy in Improving Adenoma Detection in Lynch Syndrome Cohort Undergoing Surveillance with High-Resolution Colonoscopy: A Real-World Evidence Study. Dig Dis. 2021 Aug 24; doi: 10.1159/000518840. Epub 2021 Aug 24. PMID: 34515093.
Copy Download .nbib Format: NLM
Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia.

Cancer cell

Konishi Y, Sklavenitis-Pistofidis R, Yue H, Ferrari F, Redd RA, Lightbody ED, Russo M, Perry J, Horowitz E, Justis AV, Shayegh NA, Savell A, Prescott J, Varmeh S, Nowak RP, Hamilton M, Auclair D, Marinac CR, Trippa L, Fischer ES, Ghobrial IM.
PMID: 34895486
Cancer Cell. 2022 Jan 10;40(1):6-8. doi: 10.1016/j.ccell.2021.12.003. Epub 2021 Dec 09.

No abstract available.

Cite
Konishi Y, Sklavenitis-Pistofidis R, Yue H, et al. Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia. Cancer Cell. 2021;40(1):6-8doi: 10.1016/j.ccell.2021.12.003.
Konishi, Y., Sklavenitis-Pistofidis, R., Yue, H., Ferrari, F., Redd, R. A., Lightbody, E. D., Russo, M., Perry, J., Horowitz, E., Justis, A. V., Shayegh, N. A., Savell, A., Prescott, J., Varmeh, S., Nowak, R. P., Hamilton, M., Auclair, D., Marinac, C. R., Trippa, L., Fischer, E. S., & Ghobrial, I. M. (2022). Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia. Cancer cell, 40(1), 6-8. https://doi.org/10.1016/j.ccell.2021.12.003
Konishi, Yoshinobu, et al. "Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia." Cancer cell vol. 40,1 (2022): 6-8. doi: https://doi.org/10.1016/j.ccell.2021.12.003
Konishi Y, Sklavenitis-Pistofidis R, Yue H, Ferrari F, Redd RA, Lightbody ED, Russo M, Perry J, Horowitz E, Justis AV, Shayegh NA, Savell A, Prescott J, Varmeh S, Nowak RP, Hamilton M, Auclair D, Marinac CR, Trippa L, Fischer ES, Ghobrial IM. Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia. Cancer Cell. 2022 Jan 10;40(1):6-8. doi: 10.1016/j.ccell.2021.12.003. Epub 2021 Dec 09. PMID: 34895486; PMCID: PMC8654583.
Copy Download .nbib Format: NLM
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes.

Brain pathology (Zurich, Switzerland)

Magrinelli F, Mariotto S, Nadali G, Todeschini G, Lanzafame M, Cavallaro T, Monaco S, Ferrari S.
PMID: 34327765
Brain Pathol. 2021 Nov;31(6):e13004. doi: 10.1111/bpa.13004. Epub 2021 Jul 30.

A 58-year-old male with B-cell chronic lymphocytic leukemia presented with fever, chest pain, and acute-onset neurological deficits suggestive of multiple strokes (A). Brain autopsy revealed softening areas in the brain parenchyma (B, C) corresponding to extensive necrosis (D) caused...

Cite
Magrinelli F, Mariotto S, Nadali G, et al. A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes. Brain Pathol. 2021;31(6):e13004doi: 10.1111/bpa.13004.
Magrinelli, F., Mariotto, S., Nadali, G., Todeschini, G., Lanzafame, M., Cavallaro, T., Monaco, S., & Ferrari, S. (2021). A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes. Brain pathology (Zurich, Switzerland), 31(6), e13004. https://doi.org/10.1111/bpa.13004
Magrinelli, Francesca, et al. "A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes." Brain pathology (Zurich, Switzerland) vol. 31,6 (2021): e13004. doi: https://doi.org/10.1111/bpa.13004
Magrinelli F, Mariotto S, Nadali G, Todeschini G, Lanzafame M, Cavallaro T, Monaco S, Ferrari S. A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes. Brain Pathol. 2021 Nov;31(6):e13004. doi: 10.1111/bpa.13004. Epub 2021 Jul 30. PMID: 34327765; PMCID: PMC8549026.
Copy Download .nbib Format: NLM
Cotransduction with MGMT and Ubiquitous or Erythroid-Specific GFP Lentiviruses Allows Enrichment of Dual-Positive Hematopoietic Progenitor Cells In Vivo.

ISRN hematology

Roth JC, Ismail M, Reese JS, Lingas KT, Ferrari G, Gerson SL.
PMID: 22888445
ISRN Hematol. 2012;2012:212586. doi: 10.5402/2012/212586. Epub 2012 Jul 19.

The P140K point mutant of MGMT allows robust hematopoietic stem cell (HSC) enrichment in vivo. Thus, dual-gene vectors that couple MGMT and therapeutic gene expression have allowed enrichment of gene-corrected HSCs in animal models. However, expression levels from dual-gene...

Cite
Roth JC, Ismail M, Reese JS, et al. Cotransduction with MGMT and Ubiquitous or Erythroid-Specific GFP Lentiviruses Allows Enrichment of Dual-Positive Hematopoietic Progenitor Cells In Vivo. ISRN Hematol. 2012;2012:212586doi: 10.5402/2012/212586.
Roth, J. C., Ismail, M., Reese, J. S., Lingas, K. T., Ferrari, G., & Gerson, S. L. (2012). Cotransduction with MGMT and Ubiquitous or Erythroid-Specific GFP Lentiviruses Allows Enrichment of Dual-Positive Hematopoietic Progenitor Cells In Vivo. ISRN hematology, 2012212586. https://doi.org/10.5402/2012/212586
Roth, Justin C, et al. "Cotransduction with MGMT and Ubiquitous or Erythroid-Specific GFP Lentiviruses Allows Enrichment of Dual-Positive Hematopoietic Progenitor Cells In Vivo." ISRN hematology vol. 2012 (2012): 212586. doi: https://doi.org/10.5402/2012/212586
Roth JC, Ismail M, Reese JS, Lingas KT, Ferrari G, Gerson SL. Cotransduction with MGMT and Ubiquitous or Erythroid-Specific GFP Lentiviruses Allows Enrichment of Dual-Positive Hematopoietic Progenitor Cells In Vivo. ISRN Hematol. 2012;2012:212586. doi: 10.5402/2012/212586. Epub 2012 Jul 19. PMID: 22888445; PMCID: PMC3408655.
Copy Download .nbib Format: NLM
Effect of Rapid Respiratory Virus Testing on Antibiotic Prescribing Among Children Presenting to the Emergency Department With Acute Respiratory Illness: A Randomized Clinical Trial.

JAMA network open

Rao S, Lamb MM, Moss A, Mistry RD, Grice K, Ahmed W, Santos-Cantu D, Kitchen E, Patel C, Ferrari I, Dominguez SR.
PMID: 34086034
JAMA Netw Open. 2021 Jun 01;4(6):e2111836. doi: 10.1001/jamanetworkopen.2021.11836.

IMPORTANCE: There is high usage of antibiotics in the emergency department (ED) for children with acute respiratory illnesses. Studies have reported decreased antibiotic use among inpatients with rapid respiratory pathogen (RRP) testing.OBJECTIVE: To determine whether RRP testing leads to...

Cite
Rao S, Lamb MM, Moss A, et al. Effect of Rapid Respiratory Virus Testing on Antibiotic Prescribing Among Children Presenting to the Emergency Department With Acute Respiratory Illness: A Randomized Clinical Trial. JAMA Netw Open. 2021;4(6):e2111836doi: 10.1001/jamanetworkopen.2021.11836.
Rao, S., Lamb, M. M., Moss, A., Mistry, R. D., Grice, K., Ahmed, W., Santos-Cantu, D., Kitchen, E., Patel, C., Ferrari, I., & Dominguez, S. R. (2021). Effect of Rapid Respiratory Virus Testing on Antibiotic Prescribing Among Children Presenting to the Emergency Department With Acute Respiratory Illness: A Randomized Clinical Trial. JAMA network open, 4(6), e2111836. https://doi.org/10.1001/jamanetworkopen.2021.11836
Rao, Suchitra, et al. "Effect of Rapid Respiratory Virus Testing on Antibiotic Prescribing Among Children Presenting to the Emergency Department With Acute Respiratory Illness: A Randomized Clinical Trial." JAMA network open vol. 4,6 (2021): e2111836. doi: https://doi.org/10.1001/jamanetworkopen.2021.11836
Rao S, Lamb MM, Moss A, Mistry RD, Grice K, Ahmed W, Santos-Cantu D, Kitchen E, Patel C, Ferrari I, Dominguez SR. Effect of Rapid Respiratory Virus Testing on Antibiotic Prescribing Among Children Presenting to the Emergency Department With Acute Respiratory Illness: A Randomized Clinical Trial. JAMA Netw Open. 2021 Jun 01;4(6):e2111836. doi: 10.1001/jamanetworkopen.2021.11836. PMID: 34086034; PMCID: PMC8178728.
Copy Download .nbib Format: NLM
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.

Nature

Cameroni E, Bowen JE, Rosen LE, Saliba C, Zepeda SK, Culap K, Pinto D, VanBlargan LA, De Marco A, di Iulio J, Zatta F, Kaiser H, Noack J, Farhat N, Czudnochowski N, Havenar-Daughton C, Sprouse KR, Dillen JR, Powell AE, Chen A, Maher C, Yin L, Sun D, Soriaga L, Bassi J, Silacci-Fregni C, Gustafsson C, Franko NM, Logue J, Iqbal NT, Mazzitelli I, Geffner J, Grifantini R, Chu H, Gori A, Riva A, Giannini O, Ceschi A, Ferrari P, Cippà PE, Franzetti-Pellanda A, Garzoni C, Halfmann PJ, Kawaoka Y, Hebner C, Purcell LA, Piccoli L, Pizzuto MS, Walls AC, Diamond MS, Telenti A, Virgin HW, Lanzavecchia A, Snell G, Veesler D, Corti D.
PMID: 35016195
Nature. 2021 Dec 23; doi: 10.1038/s41586-021-04386-2. Epub 2021 Dec 23.

The recently emerged SARS-CoV-2 Omicron variant encodes 37 amino acid substitutions in the spike (S) protein, 15 of which are in the receptor-binding domain (RBD), thereby raising concerns about the effectiveness of available vaccines and antibody therapeutics. Here, we...

Cite
Cameroni E, Bowen JE, Rosen LE, et al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature. 2021;doi: 10.1038/s41586-021-04386-2.
Cameroni, E., Bowen, J. E., Rosen, L. E., Saliba, C., Zepeda, S. K., Culap, K., Pinto, D., VanBlargan, L. A., De Marco, A., di Iulio, J., Zatta, F., Kaiser, H., Noack, J., Farhat, N., Czudnochowski, N., Havenar-Daughton, C., Sprouse, K. R., Dillen, J. R., Powell, A. E., Chen, A., Maher, C., Yin, L., Sun, D., Soriaga, L., Bassi, J., Silacci-Fregni, C., Gustafsson, C., Franko, N. M., Logue, J., Iqbal, N. T., Mazzitelli, I., Geffner, J., Grifantini, R., Chu, H., Gori, A., Riva, A., Giannini, O., Ceschi, A., Ferrari, P., Cippà, P. E., Franzetti-Pellanda, A., Garzoni, C., Halfmann, P. J., Kawaoka, Y., Hebner, C., Purcell, L. A., Piccoli, L., Pizzuto, M. S., Walls, A. C., Diamond, M. S., Telenti, A., Virgin, H. W., Lanzavecchia, A., Snell, G., Veesler, D., & Corti, D. (2021). Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature, . https://doi.org/10.1038/s41586-021-04386-2
Cameroni, Elisabetta, et al. "Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift." Nature vol. (2021). doi: https://doi.org/10.1038/s41586-021-04386-2
Cameroni E, Bowen JE, Rosen LE, Saliba C, Zepeda SK, Culap K, Pinto D, VanBlargan LA, De Marco A, di Iulio J, Zatta F, Kaiser H, Noack J, Farhat N, Czudnochowski N, Havenar-Daughton C, Sprouse KR, Dillen JR, Powell AE, Chen A, Maher C, Yin L, Sun D, Soriaga L, Bassi J, Silacci-Fregni C, Gustafsson C, Franko NM, Logue J, Iqbal NT, Mazzitelli I, Geffner J, Grifantini R, Chu H, Gori A, Riva A, Giannini O, Ceschi A, Ferrari P, Cippà PE, Franzetti-Pellanda A, Garzoni C, Halfmann PJ, Kawaoka Y, Hebner C, Purcell LA, Piccoli L, Pizzuto MS, Walls AC, Diamond MS, Telenti A, Virgin HW, Lanzavecchia A, Snell G, Veesler D, Corti D. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature. 2021 Dec 23; doi: 10.1038/s41586-021-04386-2. Epub 2021 Dec 23. PMID: 35016195.
Copy Download .nbib Format: NLM
Showing 2917 to 2928 of 2928 entries